Karah Parschauer - Jun 10, 2021 Form 4 Insider Report for Ultragenyx Pharmaceutical Inc. (RARE)

Role
EVP and General Counsel
Signature
/s/ Karah Parschauer
Stock symbol
RARE
Transactions as of
Jun 10, 2021
Transactions value $
-$132,900
Form type
4
Date filed
6/11/2021, 09:08 PM
Previous filing
May 10, 2021
Next filing
Jun 22, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RARE Common Stock Sale -$133K -1.33K -4.43% $100.00 28.7K Jun 10, 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a trading plan adopted by the Reporting Person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
F2 Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.